Nikodijević et al., 1990 - Google Patents
Characterization of the locomotor depression produced by an A2‐selective adenosine agonistNikodijević et al., 1990
View PDF- Document ID
- 5873439636809444865
- Author
- Nikodijević O
- Daly J
- Jacobson K
- Publication year
- Publication venue
- FEBS letters
External Links
Snippet
Adenosine analogs, such as N6‐cyclohexyladenosine (CHA) that are selective for A1‐ adenosine receptors, and analogs, such as 5'‐N‐ethylcarboxamidoadenosine (NECA) that are active at both a1 and A2 receptors, cause a profound depression of locomotor activity in …
- 230000003137 locomotive 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nikodijević et al. | Characterization of the locomotor depression produced by an A2‐selective adenosine agonist | |
| Nikodijević et al. | Behavioral effects of A1-and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. | |
| Jacobson et al. | 8-(3-Chlorostyryl) caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo | |
| Pelleg et al. | The pharmacology of adenosine | |
| Forsythe et al. | Adenosine, mast cells and asthma | |
| Jacobson et al. | A role for central A3-adenosine receptors: Mediation of behavioral depressant effects | |
| Mann et al. | Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma | |
| Nikodijević et al. | Locomotor activity in mice during chronic treatment with caffeine and withdrawal | |
| Kopf et al. | Adenosine and memory storage | |
| Belardinelli et al. | The A2A adenosine receptor mediates coronary vasodilation | |
| Mah et al. | Adenosine-dependent formation of cyclic AMP in brain slices | |
| Spicuzza et al. | Adenosine in the airways: implications and applications | |
| Berman et al. | Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats | |
| Von Lubitz et al. | The effects of adenosine A3 receptor stimulation on seizures in mice | |
| Ferré et al. | Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice | |
| De Sarro et al. | Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice | |
| Hooper et al. | Effects of purine analogues on spontaneous alternation in mice | |
| Baumgold et al. | Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding | |
| Anderson et al. | Characterization of the adenosine receptors mediating hypothermia in the conscious mouse | |
| Adami et al. | Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat | |
| Von Lubitz et al. | Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist | |
| Poucher et al. | The role of adenosine in exercise hyperaemia of the gracilis muscle in anaesthetized cats. | |
| Ahlijanian et al. | Changes in adenosine receptor sensitivity in morphine-tolerant and-dependent mice. | |
| Perkins et al. | Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action | |
| Radulovacki | Adenosine and sleep |